GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Snai1
|
ENSMUSG00000042821.7 | snail family zinc finger 1 |
Zeb1
|
ENSMUSG00000024238.7 | zinc finger E-box binding homeobox 1 |
Snai2
|
ENSMUSG00000022676.6 | snail family zinc finger 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Snai1 | mm10_v2_chr2_+_167538192_167538210 | 0.48 | 2.9e-03 | Click! |
Snai2 | mm10_v2_chr16_+_14705832_14705858 | -0.37 | 2.8e-02 | Click! |
Zeb1 | mm10_v2_chr18_+_5591860_5591902 | -0.11 | 5.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_137430517 | 18.82 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr4_-_137409777 | 12.50 |
ENSMUST00000024200.6
|
Gm13011
|
predicted gene 13011 |
chr2_-_28563362 | 11.34 |
ENSMUST00000028161.5
|
Cel
|
carboxyl ester lipase |
chr19_+_52264323 | 10.26 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr6_+_114131229 | 9.35 |
ENSMUST00000032451.7
|
Slc6a11
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
chr8_-_105933832 | 8.63 |
ENSMUST00000034368.6
|
Ctrl
|
chymotrypsin-like |
chr6_+_41458923 | 8.47 |
ENSMUST00000031910.7
|
Prss1
|
protease, serine, 1 (trypsin 1) |
chr7_-_142578093 | 7.64 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr8_-_122460666 | 7.61 |
ENSMUST00000006762.5
|
Snai3
|
snail homolog 3 (Drosophila) |
chr7_-_142578139 | 7.26 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr6_+_41392356 | 7.00 |
ENSMUST00000049079.7
|
Gm5771
|
predicted gene 5771 |
chr16_-_23890805 | 6.86 |
ENSMUST00000004480.3
|
Sst
|
somatostatin |
chr6_-_41035501 | 6.78 |
ENSMUST00000031931.5
|
2210010C04Rik
|
RIKEN cDNA 2210010C04 gene |
chr3_-_20275659 | 6.66 |
ENSMUST00000011607.5
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chr11_+_69965396 | 6.52 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr7_-_142679533 | 6.35 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr6_+_30639218 | 5.87 |
ENSMUST00000031806.9
|
Cpa1
|
carboxypeptidase A1, pancreatic |
chr10_+_75564086 | 5.57 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr4_-_116167591 | 5.53 |
ENSMUST00000030465.3
ENSMUST00000143426.1 |
Tspan1
|
tetraspanin 1 |
chr6_+_78425973 | 5.31 |
ENSMUST00000079926.5
|
Reg1
|
regenerating islet-derived 1 |
chr6_+_41354105 | 5.25 |
ENSMUST00000072103.5
|
Try10
|
trypsin 10 |
chr1_+_72824482 | 5.21 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr9_-_21312255 | 4.87 |
ENSMUST00000115433.3
ENSMUST00000003397.7 |
Ap1m2
|
adaptor protein complex AP-1, mu 2 subunit |
chr7_-_142657466 | 4.85 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr8_-_111691002 | 4.81 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr17_-_26201363 | 4.67 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr15_+_85017138 | 4.52 |
ENSMUST00000023070.5
|
Upk3a
|
uroplakin 3A |
chr7_+_18884679 | 4.40 |
ENSMUST00000032573.6
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr6_+_41521782 | 4.33 |
ENSMUST00000070380.4
|
Prss2
|
protease, serine, 2 |
chr6_-_41446062 | 4.32 |
ENSMUST00000095999.5
|
Gm10334
|
predicted gene 10334 |
chr17_-_26201328 | 4.17 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr12_+_110279228 | 4.17 |
ENSMUST00000097228.4
|
Dio3
|
deiodinase, iodothyronine type III |
chr6_-_41314700 | 4.16 |
ENSMUST00000064324.5
|
Try5
|
trypsin 5 |
chr1_+_93006328 | 4.16 |
ENSMUST00000059676.4
|
Aqp12
|
aquaporin 12 |
chr3_-_108536466 | 4.15 |
ENSMUST00000048012.6
ENSMUST00000106626.2 ENSMUST00000106625.3 |
5330417C22Rik
|
RIKEN cDNA 5330417C22 gene |
chr4_+_49059256 | 4.10 |
ENSMUST00000076670.2
|
E130309F12Rik
|
RIKEN cDNA E130309F12 gene |
chr4_+_155469114 | 4.04 |
ENSMUST00000178188.1
ENSMUST00000178238.1 ENSMUST00000023920.2 |
Tmem52
|
transmembrane protein 52 |
chr2_+_122637844 | 3.96 |
ENSMUST00000047498.8
|
AA467197
|
expressed sequence AA467197 |
chr14_+_103650208 | 3.96 |
ENSMUST00000069443.7
|
Slain1
|
SLAIN motif family, member 1 |
chr4_+_133480126 | 3.89 |
ENSMUST00000051676.6
|
Fam46b
|
family with sequence similarity 46, member B |
chr14_-_56102458 | 3.81 |
ENSMUST00000015583.1
|
Ctsg
|
cathepsin G |
chr12_-_4592927 | 3.64 |
ENSMUST00000170816.1
|
Gm3625
|
predicted gene 3625 |
chr1_-_134234492 | 3.63 |
ENSMUST00000169927.1
|
Adora1
|
adenosine A1 receptor |
chr15_+_89322969 | 3.59 |
ENSMUST00000066991.5
|
Adm2
|
adrenomedullin 2 |
chr2_+_122637867 | 3.51 |
ENSMUST00000110512.3
|
AA467197
|
expressed sequence AA467197 |
chr3_-_107221722 | 3.41 |
ENSMUST00000029504.8
|
Cym
|
chymosin |
chr9_+_46269069 | 3.41 |
ENSMUST00000034584.3
|
Apoa5
|
apolipoprotein A-V |
chrX_-_52613936 | 3.37 |
ENSMUST00000114857.1
|
Gpc3
|
glypican 3 |
chr10_-_128401218 | 3.36 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr4_-_141416002 | 3.34 |
ENSMUST00000006378.2
ENSMUST00000105788.1 |
Clcnkb
|
chloride channel Kb |
chr3_-_92485886 | 3.31 |
ENSMUST00000054599.7
|
Sprr1a
|
small proline-rich protein 1A |
chrX_-_52613913 | 3.30 |
ENSMUST00000069360.7
|
Gpc3
|
glypican 3 |
chr3_+_89229046 | 3.27 |
ENSMUST00000041142.3
|
Muc1
|
mucin 1, transmembrane |
chr6_+_41302265 | 3.22 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr8_+_71597648 | 3.18 |
ENSMUST00000143662.1
|
Fam129c
|
family with sequence similarity 129, member C |
chr5_-_100159261 | 3.15 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr1_+_74791516 | 3.14 |
ENSMUST00000006718.8
|
Wnt10a
|
wingless related MMTV integration site 10a |
chr2_-_62483637 | 3.13 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
Gcg
|
glucagon |
chr14_-_20269162 | 3.06 |
ENSMUST00000024155.7
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr2_-_30474199 | 3.06 |
ENSMUST00000065134.2
|
Ier5l
|
immediate early response 5-like |
chr16_+_36693972 | 3.04 |
ENSMUST00000023617.6
ENSMUST00000089618.3 |
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr6_-_88874597 | 3.04 |
ENSMUST00000061262.4
ENSMUST00000140455.1 ENSMUST00000145780.1 |
Podxl2
|
podocalyxin-like 2 |
chr12_-_76709997 | 3.04 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chrX_-_162964557 | 3.04 |
ENSMUST00000038769.2
|
S100g
|
S100 calcium binding protein G |
chr3_-_113532288 | 3.02 |
ENSMUST00000132353.1
|
Amy2a1
|
amylase 2a1 |
chr5_-_122049822 | 2.99 |
ENSMUST00000111752.3
|
Cux2
|
cut-like homeobox 2 |
chr10_+_75573448 | 2.99 |
ENSMUST00000006508.3
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_+_164940742 | 2.97 |
ENSMUST00000137626.1
|
Mmp9
|
matrix metallopeptidase 9 |
chr17_-_31144271 | 2.96 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr11_+_68556186 | 2.96 |
ENSMUST00000053211.6
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr7_-_126704179 | 2.96 |
ENSMUST00000106364.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr10_+_75568648 | 2.94 |
ENSMUST00000134503.1
ENSMUST00000125770.1 ENSMUST00000128886.1 ENSMUST00000151212.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr5_-_124862368 | 2.94 |
ENSMUST00000036206.7
|
Ccdc92
|
coiled-coil domain containing 92 |
chr3_-_113324052 | 2.93 |
ENSMUST00000179314.1
|
Amy2a3
|
amylase 2a3 |
chr3_-_113291449 | 2.92 |
ENSMUST00000179568.1
|
Amy2a4
|
amylase 2a4 |
chr16_+_36694024 | 2.91 |
ENSMUST00000119464.1
|
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr3_-_113258837 | 2.89 |
ENSMUST00000098673.3
|
Amy2a5
|
amylase 2a5 |
chr11_+_103171081 | 2.89 |
ENSMUST00000042286.5
|
Fmnl1
|
formin-like 1 |
chr10_-_128400448 | 2.88 |
ENSMUST00000167859.1
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr2_+_119237351 | 2.87 |
ENSMUST00000028783.7
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr7_+_45617575 | 2.85 |
ENSMUST00000008605.5
|
Fut1
|
fucosyltransferase 1 |
chr16_-_18621366 | 2.84 |
ENSMUST00000051160.2
|
Gp1bb
|
glycoprotein Ib, beta polypeptide |
chr6_+_40964760 | 2.82 |
ENSMUST00000076638.5
|
1810009J06Rik
|
RIKEN cDNA 1810009J06 gene |
chr12_+_82616885 | 2.81 |
ENSMUST00000161801.1
|
Rgs6
|
regulator of G-protein signaling 6 |
chr15_-_97908261 | 2.79 |
ENSMUST00000023119.8
|
Vdr
|
vitamin D receptor |
chr15_-_85581809 | 2.78 |
ENSMUST00000023015.7
|
Wnt7b
|
wingless-related MMTV integration site 7B |
chr5_+_115466234 | 2.78 |
ENSMUST00000145785.1
ENSMUST00000031495.4 ENSMUST00000112071.1 ENSMUST00000125568.1 |
Pla2g1b
|
phospholipase A2, group IB, pancreas |
chr11_+_69964758 | 2.77 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr9_+_110419750 | 2.77 |
ENSMUST00000035061.6
|
Ngp
|
neutrophilic granule protein |
chr6_-_78378851 | 2.74 |
ENSMUST00000089667.1
ENSMUST00000167492.1 |
Reg3d
|
regenerating islet-derived 3 delta |
chr17_-_56117265 | 2.72 |
ENSMUST00000113072.2
|
Plin5
|
perilipin 5 |
chr2_+_119237453 | 2.72 |
ENSMUST00000110816.1
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr9_+_111019284 | 2.71 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr8_-_70439557 | 2.66 |
ENSMUST00000076615.5
|
Crtc1
|
CREB regulated transcription coactivator 1 |
chr6_-_40999479 | 2.64 |
ENSMUST00000166306.1
|
Gm2663
|
predicted gene 2663 |
chr12_+_109459843 | 2.63 |
ENSMUST00000173812.1
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr4_-_141825997 | 2.63 |
ENSMUST00000102481.3
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr17_-_56117577 | 2.62 |
ENSMUST00000019808.5
|
Plin5
|
perilipin 5 |
chr11_+_87793470 | 2.59 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr6_+_29398920 | 2.58 |
ENSMUST00000181464.1
ENSMUST00000180829.1 |
Ccdc136
|
coiled-coil domain containing 136 |
chr18_-_35649349 | 2.58 |
ENSMUST00000025211.4
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr17_+_23679363 | 2.57 |
ENSMUST00000024699.2
|
Cldn6
|
claudin 6 |
chr2_-_114013619 | 2.57 |
ENSMUST00000090275.4
|
Gjd2
|
gap junction protein, delta 2 |
chr18_+_34840575 | 2.55 |
ENSMUST00000043484.7
|
Reep2
|
receptor accessory protein 2 |
chr19_-_11266122 | 2.52 |
ENSMUST00000169159.1
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr10_+_75568630 | 2.51 |
ENSMUST00000145928.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr5_+_135980099 | 2.50 |
ENSMUST00000005073.6
|
Zp3
|
zona pellucida glycoprotein 3 |
chr6_-_69631933 | 2.49 |
ENSMUST00000177697.1
|
Igkv4-54
|
immunoglobulin kappa chain variable 4-54 |
chr1_-_75133866 | 2.49 |
ENSMUST00000027405.4
|
Slc23a3
|
solute carrier family 23 (nucleobase transporters), member 3 |
chr4_-_11386757 | 2.48 |
ENSMUST00000108313.1
ENSMUST00000108311.2 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr4_+_137707458 | 2.48 |
ENSMUST00000097837.4
|
Rap1gap
|
Rap1 GTPase-activating protein |
chr11_-_46312220 | 2.48 |
ENSMUST00000129474.1
ENSMUST00000093166.4 ENSMUST00000165599.2 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr6_-_41377604 | 2.48 |
ENSMUST00000096003.5
|
Prss3
|
protease, serine, 3 |
chr8_-_64693027 | 2.47 |
ENSMUST00000048967.7
|
Cpe
|
carboxypeptidase E |
chr9_-_121792478 | 2.46 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr11_-_5152218 | 2.44 |
ENSMUST00000163299.1
ENSMUST00000062821.6 |
Emid1
|
EMI domain containing 1 |
chr9_-_75683992 | 2.43 |
ENSMUST00000034699.6
|
Scg3
|
secretogranin III |
chr8_-_46211284 | 2.43 |
ENSMUST00000034049.4
|
Slc25a4
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
chr12_-_112929415 | 2.41 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr7_+_45639964 | 2.41 |
ENSMUST00000148532.1
|
Mamstr
|
MEF2 activating motif and SAP domain containing transcriptional regulator |
chr8_+_84148025 | 2.40 |
ENSMUST00000143833.1
ENSMUST00000118856.1 |
4930432K21Rik
|
RIKEN cDNA 4930432K21 gene |
chr17_-_23684019 | 2.40 |
ENSMUST00000085989.5
|
Cldn9
|
claudin 9 |
chr2_-_163918683 | 2.39 |
ENSMUST00000044734.2
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr2_-_28084877 | 2.39 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
chr2_-_54085542 | 2.38 |
ENSMUST00000100089.2
|
Rprm
|
reprimo, TP53 dependent G2 arrest mediator candidate |
chrX_-_143827391 | 2.38 |
ENSMUST00000087316.5
|
Capn6
|
calpain 6 |
chr10_+_24223517 | 2.37 |
ENSMUST00000095784.2
|
Moxd1
|
monooxygenase, DBH-like 1 |
chr9_-_42124276 | 2.37 |
ENSMUST00000060989.8
|
Sorl1
|
sortilin-related receptor, LDLR class A repeats-containing |
chr11_-_102365111 | 2.37 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr10_+_128909866 | 2.36 |
ENSMUST00000026407.7
|
Cd63
|
CD63 antigen |
chr8_+_70373541 | 2.35 |
ENSMUST00000003659.7
|
Comp
|
cartilage oligomeric matrix protein |
chr7_+_26173411 | 2.35 |
ENSMUST00000082214.4
|
Cyp2b9
|
cytochrome P450, family 2, subfamily b, polypeptide 9 |
chr9_+_98490522 | 2.34 |
ENSMUST00000035029.2
|
Rbp2
|
retinol binding protein 2, cellular |
chr15_+_98634743 | 2.34 |
ENSMUST00000003442.7
|
Cacnb3
|
calcium channel, voltage-dependent, beta 3 subunit |
chr11_-_120648104 | 2.32 |
ENSMUST00000026134.2
|
Myadml2
|
myeloid-associated differentiation marker-like 2 |
chr16_+_87553313 | 2.31 |
ENSMUST00000026700.7
|
Map3k7cl
|
Map3k7 C-terminal like |
chr10_+_75948292 | 2.30 |
ENSMUST00000000926.2
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr7_+_26808880 | 2.29 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr10_+_75568641 | 2.28 |
ENSMUST00000131565.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_+_25395866 | 2.27 |
ENSMUST00000028328.2
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr2_+_119237531 | 2.27 |
ENSMUST00000110817.2
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr11_-_34208085 | 2.26 |
ENSMUST00000060271.2
|
Foxi1
|
forkhead box I1 |
chr10_+_79821006 | 2.23 |
ENSMUST00000169041.1
|
Misp
|
mitotic spindle positioning |
chr1_-_171196229 | 2.23 |
ENSMUST00000111332.1
|
Pcp4l1
|
Purkinje cell protein 4-like 1 |
chr11_-_120551126 | 2.22 |
ENSMUST00000026121.2
|
Ppp1r27
|
protein phosphatase 1, regulatory subunit 27 |
chr11_-_94242701 | 2.20 |
ENSMUST00000061469.3
|
Wfikkn2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
chr6_-_88875035 | 2.20 |
ENSMUST00000145944.1
|
Podxl2
|
podocalyxin-like 2 |
chrX_-_73660047 | 2.19 |
ENSMUST00000114472.1
|
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr7_+_121734477 | 2.19 |
ENSMUST00000000221.5
|
Scnn1g
|
sodium channel, nonvoltage-gated 1 gamma |
chr2_+_92915080 | 2.19 |
ENSMUST00000028648.2
|
Syt13
|
synaptotagmin XIII |
chr13_-_62888282 | 2.19 |
ENSMUST00000092888.4
|
Fbp1
|
fructose bisphosphatase 1 |
chr18_+_36528145 | 2.17 |
ENSMUST00000074298.6
ENSMUST00000115694.2 |
Slc4a9
|
solute carrier family 4, sodium bicarbonate cotransporter, member 9 |
chr11_-_103749815 | 2.17 |
ENSMUST00000018630.2
|
Wnt9b
|
wingless-type MMTV integration site 9B |
chr8_+_105518736 | 2.17 |
ENSMUST00000034363.5
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr11_+_7063423 | 2.16 |
ENSMUST00000020706.4
|
Adcy1
|
adenylate cyclase 1 |
chr8_-_109962127 | 2.13 |
ENSMUST00000001722.7
ENSMUST00000051430.6 |
Marveld3
|
MARVEL (membrane-associating) domain containing 3 |
chr4_-_11386679 | 2.12 |
ENSMUST00000043781.7
ENSMUST00000108310.1 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr14_-_56234650 | 2.11 |
ENSMUST00000015585.2
|
Gzmc
|
granzyme C |
chr7_+_141061274 | 2.10 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr11_+_3983704 | 2.10 |
ENSMUST00000063004.7
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
chr8_-_107065632 | 2.09 |
ENSMUST00000034393.5
|
Tmed6
|
transmembrane emp24 protein transport domain containing 6 |
chr10_+_95417352 | 2.08 |
ENSMUST00000181781.1
|
5730420D15Rik
|
RIKEN cDNA 5730420D15 gene |
chr7_-_31076656 | 2.08 |
ENSMUST00000167369.1
|
Fxyd3
|
FXYD domain-containing ion transport regulator 3 |
chr19_+_38132767 | 2.07 |
ENSMUST00000025956.5
ENSMUST00000112329.1 |
Pde6c
|
phosphodiesterase 6C, cGMP specific, cone, alpha prime |
chr11_-_101785252 | 2.07 |
ENSMUST00000164750.1
ENSMUST00000107176.1 ENSMUST00000017868.6 |
Etv4
|
ets variant gene 4 (E1A enhancer binding protein, E1AF) |
chr3_-_88548249 | 2.06 |
ENSMUST00000131775.1
ENSMUST00000008745.6 |
Rab25
|
RAB25, member RAS oncogene family |
chr16_+_20696175 | 2.06 |
ENSMUST00000128273.1
|
Fam131a
|
family with sequence similarity 131, member A |
chr10_+_79822617 | 2.04 |
ENSMUST00000046833.4
|
Misp
|
mitotic spindle positioning |
chr6_+_34412334 | 2.04 |
ENSMUST00000007449.8
|
Akr1b7
|
aldo-keto reductase family 1, member B7 |
chr3_-_100489324 | 2.04 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr7_+_13733502 | 2.04 |
ENSMUST00000086148.6
|
Sult2a2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
chr16_-_16863975 | 2.03 |
ENSMUST00000100136.3
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr11_-_69617879 | 2.01 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr11_+_3332426 | 2.01 |
ENSMUST00000136474.1
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1 |
chr1_+_74409376 | 1.99 |
ENSMUST00000027366.6
|
Vil1
|
villin 1 |
chr8_+_119700009 | 1.99 |
ENSMUST00000095171.3
|
Atp2c2
|
ATPase, Ca++ transporting, type 2C, member 2 |
chr3_-_132950043 | 1.98 |
ENSMUST00000117164.1
ENSMUST00000093971.4 ENSMUST00000042729.9 ENSMUST00000042744.9 ENSMUST00000117811.1 |
Npnt
|
nephronectin |
chr11_+_96929367 | 1.95 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
chr11_+_3290300 | 1.94 |
ENSMUST00000057089.6
ENSMUST00000093402.5 |
Patz1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr16_-_16863817 | 1.94 |
ENSMUST00000124890.1
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr4_+_133553370 | 1.93 |
ENSMUST00000042706.2
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr3_-_152166230 | 1.93 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr4_+_106622424 | 1.92 |
ENSMUST00000047922.2
|
Ttc22
|
tetratricopeptide repeat domain 22 |
chrX_-_7671341 | 1.92 |
ENSMUST00000033486.5
|
Plp2
|
proteolipid protein 2 |
chr5_-_122050102 | 1.91 |
ENSMUST00000154139.1
|
Cux2
|
cut-like homeobox 2 |
chr2_-_164404606 | 1.91 |
ENSMUST00000109359.1
ENSMUST00000109358.1 ENSMUST00000103103.3 |
Matn4
|
matrilin 4 |
chr7_-_17056669 | 1.90 |
ENSMUST00000037762.4
|
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr17_+_29093763 | 1.89 |
ENSMUST00000023829.6
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A (P21) |
chr7_+_126272589 | 1.89 |
ENSMUST00000056028.9
|
Sbk1
|
SH3-binding kinase 1 |
chr7_+_13623967 | 1.87 |
ENSMUST00000108525.2
|
Sult2a5
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 5 |
chr11_+_115462464 | 1.87 |
ENSMUST00000106532.3
ENSMUST00000092445.5 ENSMUST00000153466.1 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr5_+_91517615 | 1.86 |
ENSMUST00000040576.9
|
Parm1
|
prostate androgen-regulated mucin-like protein 1 |
chr17_-_7385305 | 1.86 |
ENSMUST00000070059.3
|
Gm9992
|
predicted gene 9992 |
chr7_-_126704522 | 1.85 |
ENSMUST00000135087.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr11_-_62648458 | 1.85 |
ENSMUST00000057194.8
|
Fam211a
|
family with sequence similarity 211, member A |
chr8_-_4259257 | 1.85 |
ENSMUST00000053252.7
|
Ctxn1
|
cortexin 1 |
chr5_-_108795352 | 1.84 |
ENSMUST00000004943.1
|
Tmed11
|
transmembrane emp24 protein transport domain containing |
chr14_-_70176787 | 1.83 |
ENSMUST00000153735.1
|
Pdlim2
|
PDZ and LIM domain 2 |
chr11_+_115974930 | 1.80 |
ENSMUST00000106460.2
|
Itgb4
|
integrin beta 4 |
chr11_+_3983636 | 1.79 |
ENSMUST00000078757.1
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.0 | 16.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
2.0 | 6.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
1.7 | 5.0 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
1.7 | 5.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
1.6 | 8.0 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
1.4 | 10.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.3 | 1.3 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.3 | 16.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.2 | 4.9 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
1.1 | 3.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.1 | 5.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.1 | 3.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.1 | 4.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.0 | 3.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.0 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 2.8 | GO:2000388 | positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
0.9 | 3.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.9 | 2.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.9 | 2.6 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.8 | 2.5 | GO:0015866 | ADP transport(GO:0015866) |
0.8 | 2.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.8 | 2.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.8 | 2.4 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.8 | 3.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.8 | 3.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.8 | 2.3 | GO:1990523 | bone regeneration(GO:1990523) |
0.8 | 2.3 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.8 | 3.0 | GO:0090345 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.8 | 5.3 | GO:0015840 | urea transport(GO:0015840) |
0.7 | 1.5 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.7 | 2.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 10.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.7 | 2.9 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.7 | 2.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.7 | 2.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.7 | 2.8 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.7 | 6.2 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.7 | 2.7 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.7 | 0.7 | GO:2000724 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.7 | 0.7 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.6 | 4.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.6 | 3.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.6 | 2.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.6 | 0.6 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
0.6 | 3.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.6 | 1.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.6 | 2.4 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.6 | 2.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.6 | 2.9 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.6 | 2.3 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 1.7 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.6 | 1.7 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
0.6 | 5.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 3.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 1.7 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.6 | 0.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.5 | 1.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.5 | 1.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.5 | 1.6 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.5 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 2.6 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.5 | 3.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 1.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.5 | 2.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 2.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.5 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 2.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.5 | 2.4 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.5 | 2.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 2.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.5 | 9.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.5 | 0.5 | GO:0060197 | cloacal septation(GO:0060197) |
0.5 | 1.8 | GO:0060032 | notochord regression(GO:0060032) |
0.5 | 2.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.5 | 1.4 | GO:0000239 | pachytene(GO:0000239) |
0.4 | 0.4 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.4 | 3.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 1.3 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.4 | 1.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 1.8 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.4 | 1.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 2.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 3.1 | GO:0030421 | defecation(GO:0030421) |
0.4 | 1.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 6.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.4 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.9 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.4 | 3.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 3.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 1.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.4 | 1.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 2.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 0.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.4 | 1.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.4 | 1.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.4 | 4.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.2 | GO:0071846 | actin filament debranching(GO:0071846) |
0.4 | 1.2 | GO:2000597 | optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.4 | 0.8 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.4 | 1.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 0.4 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.4 | 1.6 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.4 | 1.2 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.4 | 0.4 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
0.4 | 1.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 0.8 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.4 | 1.9 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.4 | 1.2 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.4 | 43.5 | GO:0007586 | digestion(GO:0007586) |
0.4 | 2.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 0.8 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.4 | 1.1 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.4 | 0.8 | GO:2000043 | regulation of cardiac cell fate specification(GO:2000043) |
0.4 | 0.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 0.4 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.4 | 1.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.4 | 1.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 1.4 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.3 | 3.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 1.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 1.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 1.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 5.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 2.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 0.7 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.3 | 3.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 5.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 1.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 3.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 3.3 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.3 | 0.6 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.3 | 1.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.3 | 1.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 4.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 3.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 1.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.3 | 0.3 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.3 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.3 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 5.1 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.3 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.3 | 1.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.3 | 3.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 10.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 0.3 | GO:0070100 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.9 | GO:0010666 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 1.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 2.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 2.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.9 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.3 | 0.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 3.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.3 | 1.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 0.3 | GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.3 | 0.6 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 1.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.3 | 1.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.3 | 0.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.3 | 1.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.3 | 0.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 0.8 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.3 | 0.8 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
0.3 | 1.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.5 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 0.5 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.3 | 0.3 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 2.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 2.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 1.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 0.8 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.3 | 0.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 2.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 0.5 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 1.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 2.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 2.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 0.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 0.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 1.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 1.2 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.2 | 1.5 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 2.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.7 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 1.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 2.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.7 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.2 | 1.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.0 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.2 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.2 | 1.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.5 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 0.7 | GO:0072003 | kidney rudiment formation(GO:0072003) |
0.2 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.2 | 1.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 4.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 2.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 1.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 4.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.9 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 1.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 5.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 1.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.9 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 3.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 3.3 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.9 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.2 | 1.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) positive regulation of progesterone secretion(GO:2000872) |
0.2 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.2 | 0.2 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.2 | 0.9 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.2 | 0.9 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.2 | 1.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.9 | GO:1905165 | peptidyl-aspartic acid modification(GO:0018197) regulation of lysosomal protein catabolic process(GO:1905165) |
0.2 | 3.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 1.5 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.6 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 0.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.2 | 0.6 | GO:0015811 | L-cystine transport(GO:0015811) |
0.2 | 1.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.6 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.2 | 0.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) hemangioblast cell differentiation(GO:0060217) |
0.2 | 0.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.4 | GO:0055093 | response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.2 | 0.4 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.2 | 0.6 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.2 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 1.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 1.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 6.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.2 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.2 | 0.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.2 | 2.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 1.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 1.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.6 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.4 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.2 | 0.8 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 1.3 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.2 | 0.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 1.7 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 2.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.2 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.2 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.7 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.2 | 0.6 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.6 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.2 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 0.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 0.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.2 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.7 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 0.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 1.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 2.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.2 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.7 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.2 | 0.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 1.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 1.0 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 1.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.5 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.2 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 1.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 1.8 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 1.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 0.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.7 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 0.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 1.8 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.2 | 0.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.3 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 1.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 1.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.3 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.2 | 0.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.5 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 4.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.2 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 1.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.5 | GO:0051944 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.6 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 0.5 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 0.5 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.2 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.1 | 1.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 1.3 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 2.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.7 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.4 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.6 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.8 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.6 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 1.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.1 | 0.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 1.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.7 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.7 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 2.0 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 2.8 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 1.0 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.3 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.1 | 1.2 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.4 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 4.9 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 1.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.1 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 1.0 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 2.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.1 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 1.3 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 2.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.4 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.4 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.9 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 1.0 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.1 | 0.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 1.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 1.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.6 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.1 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.8 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.4 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 1.5 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 1.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.5 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.2 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 1.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 1.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 2.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 1.9 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 2.2 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 0.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 1.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 2.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 1.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.9 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 1.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.1 | 0.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.1 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.6 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 1.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 4.6 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.3 | GO:0035854 | basophil differentiation(GO:0030221) eosinophil fate commitment(GO:0035854) |
0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 1.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 1.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 1.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 2.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.8 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.1 | 0.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.5 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 2.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 4.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.3 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 1.6 |